« Previous Next » Biology of Blood and Marrow Transplantation
Volume 14, Issue 12 , Pages 1365-1372 , December 2008

Albuminuria in Hematopoietic Cell Transplantation Patients: Prevalence, Clinical Associations, and Impact on Survival

Sangeeta R. Hingorani
- Department of Pediatrics, University of Washington, Seattle, Washington
- Correspondence and reprint requests: Sangeeta R. Hingorani, MD, MPH, Children's Hospital and Regional Medical Center, 4800 Sand Point Way NE, A-7931, Seattle, WA 98105.
Kristy Seidel
- Department of Pediatrics, University of Washington, Seattle, Washington
Armando Lindner
- Department of Medicine, University of Washington, Seattle, Washington
- VA Puget Sound Health Care System, Seattle, Washington
Tia Aneja
- Department of Pediatrics, University of Washington, Seattle, Washington
Gary Schoch
- Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington
George McDonald
- Department of Medicine, University of Washington, Seattle, Washington
- Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington

Received 18 March 2008 ,Accepted 17 September 2008.

Cumulative incidence curves of nonrelapse mortality from day 100 to 1 year post-HCT, displayed by degree of albuminuria (n = 43 for ACR < 30; n = 54 for ACR 30 to 300; n = 17 for ACR ≥ 300).

Cumulative incidence curves of nonrelapse mortality from day 100 to 1 year post-HCT, displayed by degree of albuminuria (n = 43 for ACR < 30; n = 54 for ACR 30 to 300; n = 17 for ACR ≥ 300).
- Full-Size Image
- Download to PowerPoint
Kaplan-Meier curves of overall survival from day 100 to 1 year post-HCT, by degree of albuminuria (n = 44 for ACR < 30; n = 58 for ACR 30 to 300; n = 18 for ACR ≥ 300).

Kaplan-Meier curves of overall survival from day 100 to 1 year post-HCT, by degree of albuminuria (n = 44 for ACR < 30; n = 58 for ACR 30 to 300; n = 18 for ACR ≥ 300).
- Full-Size Image
- Download to PowerPoint